The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi/Aventis
A multicentric phase II randomized trial of docetaxel (D) plus enzalutamide (E) versus docetaxel (D) as first-line chemotherapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): CHEIRON study.
 
Orazio Caffo
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Medivation; Janssen
 
Erica Palesandro
No Relationships to Disclose
 
Franco Nole
No Relationships to Disclose
 
Donatello Gasparro
Consulting or Advisory Role - Janssen-Cilag; Sanofi
Speakers' Bureau - Astellas Pharma; Janssen; Janssen; Pfizer; Sanofi
 
Claudia Mucciarini
No Relationships to Disclose
 
Michele Aieta
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Roberto Iacovelli
Consulting or Advisory Role - Astellas Oncology; Ipsen; Janssen; Novartis
 
Ugo De Giorgi
No Relationships to Disclose
 
Sabrina Rossetti
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Cosimo Sacco
No Relationships to Disclose
 
Maurizio Nicodemo
No Relationships to Disclose
 
Monica Giordano
No Relationships to Disclose
 
Donata Sartori
No Relationships to Disclose
 
Daniela Scapoli
No Relationships to Disclose
 
Elena Verri
No Relationships to Disclose
 
Stefania Kinspergher
No Relationships to Disclose
 
Giovanni L. Pappagallo
Honoraria - Astellas Pharma; Genzyme; Ipsen; Janssen Oncology; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Astellas Pharma; Genzyme; Ipsen; Janssen Oncology
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology
 
Massimo Aglietta
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca (Inst); PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MERCK; tesaro